MiR‐342 Controls Mycobacterium Tuberculosis Susceptibility by Modulating Inflammation and Cell Death

Beibei Fu,Xiaoyuan Lin,Shun Tan,Rui Zhang,Weiwei Xue,Haiwei Zhang,Shanfu Zhang,Qingting Zhao,Yu Wang,Kelly Feldman,Lei Shi,Shaolin Zhang,Weiqi Nian,Krishna Chaitanya Pavani,Zhifeng Li,Xingsheng Wang,Haibo Wu
DOI: https://doi.org/10.15252/embr.202052252
IF: 9.071
2021-01-01
EMBO Reports
Abstract:Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that places a heavy strain on public health. Host susceptibility to Mtb is modulated by macrophages, which regulate the balance between cell apoptosis and necrosis. However, the role of molecular switches that modulate apoptosis and necrosis during Mtb infection remains unclear. Here, we show that Mtb-susceptible mice and TB patients have relatively low miR-342-3p expression, while mice with miR-342-3p overexpression are more resistant to Mtb. We demonstrate that the miR-342-3p/SOCS6 axis regulates anti-Mtb immunity by increasing the production of inflammatory cytokines and chemokines. Most importantly, the miR-342-3p/SOCS6 axis participates in the switching between Mtb-induced apoptosis and necrosis through A20-mediated K48-linked ubiquitination and RIPK3 degradation. Our findings reveal several strategies by which the host innate immune system controls intracellular Mtb growth via the miRNA-mRNA network and pave the way for host-directed therapies targeting these pathways.
What problem does this paper attempt to address?